Download DNB 2016 Dec DERMATOLOGY VENEREOLOGY AND LEPROSY PAPER 3 Question Paper

Download Diplomate of National Board (DNB) 2016 Dec DERMATOLOGY VENEREOLOGY AND LEPROSY PAPER 3 Previous Question Paper

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
DERMATOLOGY, VENEREOLOGY & LEPROSY

PAPER ? III
DVD/D/16/06/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:
1



Sample collection and tests available for demonstration of the
microrganisms causing:
a) Bacterial vaginosis.
b) Herpes genitalis.
c) Chancre.
3+3+4
2



Manifestations of the following in a patient who has a
concomitant HIV infection:
a) Secondary syphilis.
b) Anogenital warts.
c) Molluscum contagiosum.

4+3+3
3 Significance of the following in a patient who has history of high
risk sexual behavior:
a) Lymphadenopathy.
b) Skin rash.
c) Oral lesions.

4+4+2
4 How will you manage?
a) Pregnant woman with anogenital warts.
b) Partner of a patient with gonococcal cervicitis.
c) A child who presents immediately after sexual assault.

3+2+5

5. Complications of:
a) Sexually transmitted reactive arthritis.
b) Chlamydia trachomatis cervicitis.
c) Lymphogranuloma venereum.

4+4+2


6 Role of the following in a patient with lepromatous leprosy:
a) Radiological evaluation.
b) Counseling.
c) Platelet rich plasma.





4+4+2







P.T.O.
FirstRanker.com - FirstRanker's Choice
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-1-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
DERMATOLOGY, VENEREOLOGY & LEPROSY

PAPER ? III
DVD/D/16/06/III
Time : 3 hours
Max. Marks : 100

Important instructions:

? Attempt all questions in order.
? Each question carries 10 marks.
? Read the question carefully and answer to the point neatly and legibly.
? Do not leave any blank pages between two answers.
? Indicate the question number correctly for the answer in the margin space.
? Answer all the parts of a single question together.
? Start the answer to a question on a fresh page or leave adequate space between two answers.
? Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:
1



Sample collection and tests available for demonstration of the
microrganisms causing:
a) Bacterial vaginosis.
b) Herpes genitalis.
c) Chancre.
3+3+4
2



Manifestations of the following in a patient who has a
concomitant HIV infection:
a) Secondary syphilis.
b) Anogenital warts.
c) Molluscum contagiosum.

4+3+3
3 Significance of the following in a patient who has history of high
risk sexual behavior:
a) Lymphadenopathy.
b) Skin rash.
c) Oral lesions.

4+4+2
4 How will you manage?
a) Pregnant woman with anogenital warts.
b) Partner of a patient with gonococcal cervicitis.
c) A child who presents immediately after sexual assault.

3+2+5

5. Complications of:
a) Sexually transmitted reactive arthritis.
b) Chlamydia trachomatis cervicitis.
c) Lymphogranuloma venereum.

4+4+2


6 Role of the following in a patient with lepromatous leprosy:
a) Radiological evaluation.
b) Counseling.
c) Platelet rich plasma.





4+4+2







P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016
-2-
POSSESSION / USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

DERMATOLOGY, VENEREOLOGY & LEPROSY

PAPER ? III






7 Extracutaneous manifestations of leprosy under the following heads:
a) Nerve involvement.
b) Renal involvement.
c) Eye involvement.

4+2+4

8 a) Drug resistance in leprosy and its evaluation.
b) Serological markers in leprosy.
(4+2)+4

9
a) Management of recurrent, steroid dependent type 2 reaction.
b) Management of lagophthalmus.
5+5

10 a) Vaccines in leprosy.
b) Epidemiological parameters used for leprosy control.
c) Treatment of pulmonary tuberculosis in a patient with multibacillary
leprosy.
3+5+2


**********************
FirstRanker.com - FirstRanker's Choice